Pump and sensor technology that helps you stay in range.5 Always read the Instructions for Use.
Methods: FGM (FreeStyle Libre Pro; Abbott Japan) and a sensor-augmented pump (SAP) with built-in CGM (MiniMed 620G; Medtronic Minimed) were simultaneously put in place in 8 outpatients with type 1 diabetes receiving SAP therapy (Age, 50.9 ± 6.3 years; BMI, 20.4±2.6 kg/m 2; HbA1c, 7.4±0.3%; urinary C-peptide excretion, 1.5±0.7 µg/day. June 2019 – MiniMed pumps with certain software versions recalled over hacking concerns; September 2017 – MiniMed pumps recalled due to potential for a blocked pump membrane which may result in insulin dosing error; September 2015 – MiniMed 620G and 640G pumps recalled because of malfunctioning drive motor and malfunctioning timer.
Waterproof protection up to 3.6m for up to 24 hours*
Full colour auto-brightness display
SmartGuard® technology to help protect you from lows
Airplane mode for travel
Easy to use menu and buttons
Personalised basal and Bolus™ settings
Active insulin tracking
Wireless readings and discreet remote bolusing
Bolus™ Wizard® Calculator for recommended doses
Predictive alerts for highs and lows
Many factors can affect your glucose levels, such as diet, exercise and stress levels. You may need a system that can give you better control: a system that thinks1. The MiniMed® 640G System^ with SmartGuard® technology closely mimics the way a healthy pancreas delivers background insulin to the body.
All of this with personalised settings to fit in with your daily life. The MiniMed® 640G System gives you better control2 by providing advanced protection from hypoglycaemia3 and greater convenience for easier daily management of your diabetes.
Medtronic’s (real-time) continuous glucose monitoring (CGM) products are indicated for use by people living with type one diabetes. Guardian™ Sensor 3 may be used as part of the MiniMed® 640G system for ages 2 and up. Sensor is indicated for use on arm and abdomen. Enlite™ Sensors are indicated for use with MiniMed® 640G system for people age 7 and up. Sensor is indicated for use on abdomen, buttock and upper buttock.
|Enlite™ Sensor||Guardian™ Sensor 3|
|Available age 7 and up||Available age 2 and up|
Medtronic’s (real-time) continuous glucose monitoring (CGM) products are indicated for use by people living with type one diabetes. Guardian™ Sensor 3 may be used as part of the Guardian™ Connect and MiniMed® 640G systems for ages 2 and up. Sensor is indicated for use on arm and abdomen. Guardian™ Sensor 3 may also be used as part of the MiniMed® 670G system for people living with type 1 diabetes age 7 and up. Sensor is indicated for use on abdomen only. Enlite™ Sensors are indicated for use with Guardian™ Connect, Paradigm™ VEO and MiniMed® 640G systems for people living with type 1 diabetes, age 7 and up. Sensor is indicated for use on abdomen, buttock and upper buttock.
Our infusion sets with the innovative MiniMed® connection are designed to provide a more secure insulin delivery from your pump to your body. The infusion sets come in a diverse range of colours and styles to meet your lifestyle needs, allowing you to be more comfortable and confident!
Continuous Glucose Monitoring (CGM) technology tracks glucose levels in your body 24 hours a day. CGM uses a sensor that connects to your MiniMed® insulin pump5 giving you early warnings of highs and lows. Results show that CGM can lower HbA1c levels2 and reduce the time of hypos4, and aims to improve quality of life.
The Bayer CONTOUR™ NEXT LINK 2.4 is the only available blood glucose meter shown to accurately send glucose readings wirelessly to your MiniMed® 640G saving you time and effort. It also allows you to discreetly send a Bolus™ directly to your pump and to conveniently download blood glucose and insulin information to CareLink™.
CareLink™ Personal Software is a convenient online tool that accurately tracks your insulin usage and glucose levels, allowing you to compare any changes in glucose levels with your daily activities, such as meals and exercise routines. Clear charts and graphs show you these changes and help you and your healthcare provider discover patterns and adjust your therapy for beter control.
Request a call today, to discuss the benefits of an Insulin Pump Therapy with a Medtronic Diabetes Therapy Consultant.
Be sure to discuss questions specific to your health and treatments with a healthcare professional.Quick Summary
The FDA has announced that they have issued a Class I recall for Medtronic MiniMed Insulin Pumps including:
The recall may affect 322,005 pumps in the U.S. The FDA says that they have received 26,421 complaints for the malfunction which may have resulted in 2,175 injuries and one death.
People who were injured by the 630G and 670G MiniMed Insulin Pumps may be considering lawsuits against Medtronic to seek compensation for their injuries.
On November 21, 2019, the FDA issued a Class I recall for the MiniMed pumps which warned of the potential for insulin overdose or underdose due to an improperly seated cartridge.
The devices may have a missing, damaged or broken retainer ring which is intended to lock the cartridge in place. If the ring is damaged or fails to lock the reservoir securely, insulin dosages may be inaccurate and result in serious hypo or hyperglycemia. Users of the pumps were advised to examine their pumps, stop using broken or pumps that fail to lock and to seek medical advice for continued insulin dosing or symptoms of illness.
In the past 10 years, Medtronic has been forced to issue multiple recalls for insulin pump, insulin set and insulin reservoir failures.
The U.S. Food and Drug Administration (FDA) announced a Class I recall issued by medical device maker, Medtronic for its MiniMed Insulin Pumps. The November 2019 announcement reportedly affected 322,005 pumps in the U.S. and thousands more around the world.
The recall was prompted by the possibility of a broken or missing retainer ring on the pump which would allow an over delivery or under delivery of insulin to the patient. Either case is potentially harmful or even life-threatening.
The FDA has received at least 26,421 error reports including 2,175 injuries and at least one death which can be attributed to the recalled pumps. Medtronic may be facing a new round of MiniMed Insulin Pump lawsuits filed by people or loved ones of those who were injured due to the malfunction.
A safety alert was issued by the FDA on November 21, 2019 notifying the public and the health care community of a Class I recall for the MiniMed Insulin Pump, manufactured by device maker Medtronic. Class 1 recalls are the highest safety risk and indicate that the device poses a high potential for serious injury or death.
The FDA’s announcement stated that the MiniMed pumps in question were being recalled due to the potential for a broken or missing retainer ring on the pump. The ring is intended to lock the reservoir cartridge of insulin supply into place. If the ring is missing or damaged, the cartridge may not properly lock and if loose, may over deliver or under deliver the insulin dose.
It includes all the file versions available to download off Uptodown for that app. Download rollbacks of Firefox for Mac. Any version of Firefox distributed on Uptodown is completely virus-free and free to download at no cost. 83.0 Nov 18th, 2020. 82.0.3 Nov 10th, 2020. 82.0 Oct 20th, 2020. 78.0.2 Jul 22nd, 2020. 78.0.2 Jul 22nd, 2020. Download Mozilla Firefox, a free Web browser. Firefox is created by a global non-profit dedicated to putting individuals in control online. Get Firefox for Windows, macOS, Linux, Android and iOS today! If you looking on the internet a Mozilla Firefox for Mac latest Version Free Download So, you come to the right place now a day shares with you an amazing application Mozilla Firefox is a fast, light and tidy open source web browser. Download Firefox for Mac 71.0 DMG for Mac OS X 10.9 or later setup free. It is a complete offline setup of Firefox for Mac with a single click download link. Download the latest version of Firefox for Mac. A multi-platform web browser with open source code. Mozilla continues to work on further improvements for its. Firefox download for macbook air. Get Firefox, a free web browser backed by Mozilla, a non-profit dedicated to internet health and privacy. Available now on Windows, Mac, Linux, Android and iOS.
Too much insulin (over delivery) may result in hypoglycemia while too little (under delivery) may result in hyperglycemia, either of which may result in serious medical harm or be life-threatening.
The recall may affect an estimated 322,000 devices in the U.S. and includes the following MiniMed 600 series insulin pump models:
The MiniMed Insulin Pump is a small drug delivery device which contains a supply of insulin to be delivered automatically to patients without requiring individual injections. The newest technology allows for a “closed-loop” system which measures the blood sugar and delivers the appropriate amount of insulin in a manner said to be an “artificial pancreas”.
The recall affects two of the most recent pumps, 630G and 670G which can be used in the automatic system. If the retainer ring that holds the insulin reservoir cartridge in place is not functioning, it may not lock securely and may result in improper insulin dosing.
Due to the recall, users of the pumps have been advised to:
Signs of hypoglycemia may include:
Signs of hyperglycemia include:
Signs of hypoglycemia or hyperglycemia should be reported to a health care provider as needed. If symptoms are severe, the condition should be treated as a medical emergency.
The November 2019, Medtronic MiniMed Insulin Pump recall is a Class I recall, indicating that it has a high risk for potential harm, however it is not the first recall Medtronic has been forced to issue for their insulin pumps.
Other recalls have included:
Due to a history of problems with the MiniMed Insulin Pumps, Medtronic has faced multiple lawsuits for injuries caused by the devices. Most of these lawsuits have been resolved or settled in the past but the company may be facing new cases.
People injured by the MiniMed 630G or 670G Insulin Pumps due to the failure of the retaining ring, may be considering filing a lawsuit to seek compensation for their injuries and should seek legal assistance.
Notwithstanding claims relating to this product, the drug/medical device remains approved by the U.S. FDA.